Oral Contraceptives Offer Some Protection Against Bone Loss in Anorexia Nervosa
For young women with anorexia nervosa, oral contraceptives may limit bone loss.
For young women with anorexia nervosa, oral contraceptives may limit bone loss.
11β-MNTDC is a modified testosterone with androgenic and progestational activity that is being developed as a potential male contraceptive.
More African-American, Hispanic, low-income respondents report delayed contraceptive initiation.
Female sterilization is most commonly used method, followed by oral contraceptive pill.
A levonorgestrel 52-mg intrauterine system was found to be safe and effective for pregnancy prevention.
A birth control coverage opt-out for employers was finalized by the Trump administration on Wednesday.
The expanded approval was supposed by safety and efficacy data from the Phase 3 ACCESS IUS trial (N=1751) in women receiving Liletta. In the trial, Liletta demonstrated >99% efficacy in preventing pregnancy for up to 5 years in a broad patient population.
Combined hormonal contraception use tied to lower risk; risk down with increasing duration of use.
Increases in use of 1 or more contraceptive methods, dual-method use, long-acting reversibles.
Current oral contraceptive products contain lower doses of estrogen than those used in the past, prompting reconsideration of risks and benefits.